亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

GSSG Liposomes for Cancer Treatment

技術優勢
GSSG is normally not able to pass through the cell membraneand, therefore, normally acts upon the cell membrane through interactions with the cell surface. The GSSG liposomes can effectively deliver GSSG into the cells. Early studies have shown the GSSG within the cells can produce antimetastatic and anti-cancer effects. Further, the GSSG liposomes can be utilized to study the effect of GSSG on cellular functions.
詳細技術說明
The developed GSSG liposomes are not only able to deliver the GSSG into the cells, but also able to inhibit cancer metastasis. Results demonstrate that the GSSG liposomes can inhibit metastasis of all four human cancer cell lines tested (lung cancer, prostate cancer, ovarian cancer, and colon cancer). The GSSG liposomes have demonstrated the potential for treating metastatic cancer. The GSSG liposomes can also be used as a tool to deliver GSSG into cells to study the impact of GSSG on cellular functions that are not well studied due to a lack of a method to deliver GSSG into the cell.
*Abstract
Cancer metastasis is the cause of cancer proliferation and treatment failure. Methods to treat metastatic cancer are needed, as few are available. SDSU has developed a liposome glutathione disulfide (GSSG) that can deliver GSSG into cells. GSSG, which cannot normally pass through the cell membrane, is an endogenous compound and an indicator for cellular oxidative stress.
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備